# Rhodes Pharmaceuticals **Rhodes Pharmaceuticals L.P.** is a Sackler-family-controlled US generic pharmaceutical manufacturer, established **in 2007 — within months of [[Purdue Pharma]]'s federal guilty plea on OxyContin misbranding**. Rhodes is best understood as the **generic-opioid arm** of the post-plea Sackler pharma footprint: producing generic oxycodone and other opioids under a different corporate label while [[Purdue Pharma]] continued to market the brand [[OxyContin]] product. The 2007 timing of Rhodes's incorporation — immediately after Purdue's federal guilty plea — has been cited by state-AG investigations and journalistic accounts as evidence of the family's strategic posture: a second corporate vehicle to continue participation in the US opioid market under a label not yet branded with the OxyContin / Purdue reputational baggage. Rhodes remained Sackler-family-controlled through the [[Purdue Pharma]] Chapter 11 process and is not part of the post-bankruptcy reorganization into Knoa Pharma. Its current status and ownership disposition under the 2025 settlement framework is incompletely documented in public sources. ## See Also - [[Sackler Family]] — the owners - [[Purdue Pharma]] — the brand-name sibling - [[Mundipharma]] — the international sibling - [[Opioid Crisis Timeline]] — Era 3 (2007 spinoff timing)